-
1Academic Journal
Authors: N. V. Palyanova, M. G. Chechenin, A. N. Trunov, I. A. Sobolev, A. M. Shestopalov, Н. В. Пальянова, М. Г. Чеченин, А. Н. Трунов, И. А. Соболев, А. М. Шестопалов
Contributors: In this research collecting of the biological material was funded by state assignment from the Ministry of Science and Higher Education of Russian Federation 122120600015-2, and analyzing of the data and laboratory diagnostics were funded by the Russian Science Foundation grant project No. 23-64-00005.
Source: Acta Biomedica Scientifica; Том 9, № 6 (2024); 34-43 ; 2587-9596 ; 2541-9420
Subject Terms: IgG, seroprevalence, vaccination, healthcare workers, non-healthcare workers, IgM, серопревалентность, вакцинация, работники здравоохранения, сотрудники, не являющиеся работниками здравоохранения
File Description: application/pdf
Relation: https://www.actabiomedica.ru/jour/article/view/5114/2931; Liviero F, Volpin A, Furlan P, Battistella M, Broggio A, Fabris L, et al. The impact of SARS-CoV-2 on healthcare workers of a large University Hospital in the Veneto Region: Risk of infection and clinical presentation in relation to different pandemic phases and some relevant determinants. Front Public Health. 2023; 11: 1250911. doi:10.3389/fpubh.2023.1250911; Palyanova N, Sobolev I, Alekseev A, Glushenko A, Kazachkova E, Markhaev A, et al. Genomic and epidemiological features of COVID-19 in the Novosibirsk Region during the beginning of the pandemic. Viruses. 2022; 14(9): 2036. doi:10.3390/v14092036; Metzger C, Leroy T, Bochnakian A, Jeulin H, GegoutPetit A, Legrand K, et al. Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic. PLoS One. 2023; 18(4): e0269104. doi:10.1371/journal.pone.0269104; Moreno-Medina K, Sáenz Pérez LD, Villar JC, Váquiro Herrera E, Pérez Franco JE, Varón-Vega FA, et al. SARS-CoV-2 seroprevalence in workers from a Colombian University Hospital. Occup Med (Lond). 2023; 73(3): 128-132. doi:10.1093/occmed/kqad003; Tariverdi M, Mohammadi H, Hassanzadeh F, Tamaddondar M. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children’s Hospital. BMC Infect Dis. 2024; 24(1): 253. doi:10.1186/s12879-023-08863-z; Williamson JC, Wierzba TF, Santacatterina M, Munawar I, Seals AL, Pittman Ballard CA, et al.; North Carolina sites of the COVID-19 Community Research Partnership. Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership. PLoS One. 2022; 17(3): e0260574. doi:10.1371/journal.pone.0260574; Krieger EA, Samodova OV, Schepina IV, Shagrov LL, Zvezdina YuM. Humoral immunity to new coronavirus infection and vitamin D level in healthcare workers. Journal Infectology. 2023; 15(2): 93-104. (In Russ.) doi:10.22625/2072-6732-2023-15-2-93-104; Blokh AI, Panyushkina II, Pakhtusova PO, Sergeeva IV, Levahina LI, Burashnikova IP, et al. Assessment of seroconversion to SARS-CoV-2 in health care unit personnel. Epidemiology and Vaccinal Prevention. 2021; 20(5): 32-38. (In Russ.) doi:10.31631/2073-3046-2021-20-5-32-38; Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARSCoV-2 infection. J Med Virol. 2020; 92(6): 589-594. doi:10.1002/jmv.25725; Lacorzana J, Ortiz-Perez S, Rubio Prats M. Incidence of COVID-19 among ophthalmology professionals. Med Clin (Barc). 2020; 155(5): 225. doi:10.1016/j.medcli.2020.05.018; Sacchi M, Lizzio RAU, Villani E, Tagliabue E, Monsellato G, Pajardi G, et al. Prevalence of SARS-CoV-2 amongst ophthalmologists throughout the first and second waves of the pandemic. Medicine (Baltimore). 2021; 100(50): e28192. doi:10.1097/MD.0000000000028192; Palyanova NV, Sobolev IA, Palyanov AY, Kurskaya OG, Komissarov AB, Danilenko DM, et al. The development of the SARSCoV-2 epidemic in different regions of Siberia in the 2020–2022 period. Viruses. 2023; 15(10): 2014. doi:10.3390/v15102014; Yandex DataLens. URL: https://datalens.yandex/7o7is1q6ikh23?tab=X1&state=42db05f5180 [date of access: 7.05.2024].; Analysis of four-field contingency tables (comparison of percentages in two groups) (online calculator). Medstatistic. (In Russ.). URL: https://medstatistic.ru/calculators/calchi.html [date of access: 7.05.2024].; Calculate confidence limits for a sample proportion. URL: https://epitools.ausvet.com.au/ciproportion [date of access: 1.12.2024].; Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, et al. Antibody response to SARS-CoV-2 infection in humans: A systematic review. PLoS One. 2020; 15(12): e0244126. doi:10.1371/journal.pone.0244126; Wang K, Long QX, Deng HJ, Hu J, Gao QZ, Zhang GJ, et al. Longitudinal dynamics of the neutralizing antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Clin Infect Dis. 2021; 73(3): e531-e539. doi:10.1093/cid/ciaa1143; Fatkhutdinova LM, Badamshina GG, Sizova EP, Patyashina MA, Stavropolskaya LV, Gabidinova GF, et al. Immune response to SARS-CoV-2 and the risk of COVID-19 among different groups of healthcare workers. Russian Journal of Occupational Health and Industrial Ecology. 2021; 61(5): 286-304. (In Russ.). doi:10.31089/1026-9428-2021-61-5-286-304; Wiggen TD, Bohn B, Ulrich AK, Stovitz SD, Strickland AJ, Naumchik BM, et al. SARS-CoV-2 seroprevalence among healthcare workers. PLoS One. 2022; 17(4): e0266410. doi:10.1371/journal.pone.0266410; Agafonova EV, Kulikov SN, Reshetnikova ID, Tyurin YuA, Gilyazutdinova GF, Lopushov DV, et al. Seroprevalence study results to SARS-CoV-2 in healthcare workers: age and professional aspects. Epidemiology and Vaccinal Prevention. 2021; 20(2): 49-57. (In Russ.). doi:10.31631/2073-3046-2021-20-2-49-57; de Visscher N, Holemans X, Gillain A, Kornreich A, Lagasse R, Piette P, et al. SARS-CoV-2 seroprevalence among healthcare workers after the first and second pandemic waves. Viruses. 2022; 14(7): 1535. doi:10.3390/v14071535; Ige FA, Ohihoin GA, Osuolale K, Dada A, Onyia N, Johnson A, et al. Seroprevalence of SARS-CoV-2 IgG among healthcare workers in Lagos, Nigeria. PLoS One. 2023; 18(10): e0292440. doi:10.1371/journal.pone.0292440; WHO. Protocol for assessment of potential risk factors for coronavirus disease 2019 (COVID‐19) among health workers in a health care setting. Version: 2.2. 2020. WHO/2019-nCoV/HCW_risk_factors_protocol/2020.3; https://www.actabiomedica.ru/jour/article/view/5114